About
Leadership
Community Outreach
Careers
Contact Us
Technology
Lenti-VEX™ Delivery Platform
Lenti-VO™ Delivery Platform
Manufacturing
Publications
Pipeline & Clinical Trials
D-Fi Gene Therapy for Dystrophic Epidermolysis Bullosa (DEB)
LV-FAH Gene Therapy
for Hereditary Tyrosinemia Type 1 (HT1)
Clinical Trials
Patients & Families
Epidermolysis Bullosa (EB)
Tyrosinemia
Newsroom
Press Releases
Events & Presentations
Media Coverage
Contact Us
Toggle navigation
Leadership
About
Leadership
Robin Blumenthal, Ph.D.
Robin Blumenthal, Ph.D.
Associate Vice President, Clinical Operations
